Cited by 24Bone Tissue Engineering MaterialsPeriodontal Regeneration and TreatmentsBone fractures and treatments

Complete regeneration of large bone defects in rats with commercially available fibrin loaded with BMP-2

Open access
Department of Orthopaedics, UMC Utrecht, G.05.228, P.O. Box 85500, 3508 GA Utrecht, the Netherlands., Koolen, M, Longoni, A, van der Stok, J, Van der Jagt, O, Gawlitta, D, Weinans, H·2019·European Cells and Materials

Abstract

This study aimed at investigating in vitro and in vivo the efficiency of commercially available fibrin as a carrier for controlled and sustained bone morphogenetic protein-2 (BMP-2) release to induce bone formation and reduce the side effects of its use. In vitro release and activity of low-dose recombinant human BMP-2 (rhBMP-2) (37.5 µg/mL) embedded in commercially available fibrin were evaluated and, subsequently, critical-size femur defects in rats were grafted to study bone regeneration and vascularisation by micro-computed tomography (µCT) and histology. In vitro experiments showed a sustained BMP-2 release with a high BMP activity remaining after 28 d. In vivo, fibrin loaded with BMP-2 showed an extremely fast bone healing, with a large amount of new bone formation throughout the entire defect in the first 4 weeks and complete cortical repair and fusion after 8 weeks, with no ectopic bone formation. In contrast, the control fibrin group did not fuse after 12 weeks. Vascularisation was similar in both groups at 4 and 12 weeks after implantation. In conclusion, commercially available fibrin is a very efficient carrier for rhBMP-2 to graft critical-size cortical bone defects and might be a more optimal delivery vehicle for BMP-2-induced bone regeneration than currently available collagen sponges.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.22203/ecm.v038a08

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Natural polymer carriers may be advantageous if they contain cell binding motifs that promote osteoconductivity.

    “Natural polymer carriers may be advantageous if they contain cell binding motifs that promote osteoconductivity. [9–12]”

    From Keratin Scaffold Formulation Impacts rhBMP-2 Biodistribution and Bone Regeneration in a Rat Femur Defect Model (2025) · cites this paper as [12]

    The Introduction (page unavailable) describes fibrin as a carrier that mimics the natural bone-regeneration environment and provides a favourable setting for cellular attachment and proliferation. It does not identify cell-binding motifs or say that those motifs promote osteoconductivity; the Discussion (page unavailable) instead describes the osteoinductive effect of BMP-containing fibrin. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 40 · Cited by 24

Authors
Department of Orthopaedics, U. U., Koolen, M., Longoni, A., van der Stok, J., Van der Jagt, O., Gawlitta, D., & Weinans, H.
Affiliations
Utrecht University (NL)
Corresponding author
Koolen, M
Venue
European Cells and Materials
Published
2019-09-17
Volume
38
Pages
94-105
ISSN
1473-2262 (ISSN-L)
OpenAlex
W2974286856
Cited by
24
References
40
Citations by year
2026: 1 · 2025: 4 · 2023: 4 · 2022: 6 · 2021: 4 · 2020: 5
FWCI
1.32
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • European Cells and Materials (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Health Sciences › Medicine › Urology › Periodontal Regeneration and Treatments
  • Health Sciences › Medicine › Epidemiology › Bone fractures and treatments
Keywords
BMP-2, fibrin, BMP-2 delivery, sustained drug release, bone regeneration, critical-size bone defect, cortical bone defect, vascularization, ectopic bone formation, collagen sponge, bone grafting
MeSH terms
Animals, Cell Line, Cells, Cultured, Femoral Fractures, Femur, Humans, Fibrin Tissue Adhesive, Fracture Healing, Rats, Wistar, Bone Substitutes, Neovascularization, Physiologic, Hydrogels, Mice, Rats, Bone Morphogenetic Protein 2, Drug Liberation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review